UNSPSC 51314390: Acetaminophen/dextromethorphan/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE503. This VA Drug Class (RE503) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/EXPECTORANT.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51314390 Acetaminophen/dextromethorphan/phenylephrine is a Commodity code that in recent state and local solicitations encompasses broader pharmaceutical procurement including naloxone, over-the-counter products, and generic pharmaceuticals rather than the specific combination formulation the code name suggests. State and local governments use this code and related pharmaceutical commodity codes to procure medications and health-related products for community health programs, pharmacy benefit management, and public health initiatives. Issuing bodies span county health departments, state health and human services agencies, and multistate cooperative purchasing alliances; Seminole County, Florida and the Texas Health and Human Services Commission and Minnesota Department of Administration have posted recent activity under or closely adjacent to this code.

Recent opportunities show activity concentrated in Florida and the upper Midwest with exploratory procurement underway in Texas. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida, with a response deadline of July 26, 2023 (note: deadline date appears mismatched to posted date in source). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities including Oregon, with proposals due March 26, 2026; awarded vendors must maintain relationships with authorized wholesalers AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, exploring vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, functioning as market intelligence gathering before formal RFP issuance.